Delivery Order SPE2DB22D2206-SPE2DB25FER45

Award Date 12/12/24
Potential Completion Date 1/6/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FER45
    Delivery Order

This federal contract award, identified by the ID SPE2DB22D2206|SPE2DB25FER45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $2,220.84 fixed-price delivery order is for the procurement of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, which are likely COVID-19 vaccine doses. The contract has an ultimate completion date of January 6, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation. These IDCs enable the government to efficiently procure a wide range of essential pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs. The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 3/13/25, 9:58 AM